Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1786 to 1800 of 2183 results for guidelines

  1. Dementia: supporting people with dementia and their carers in health and social care (CG42)

    This guidance has been updated and replaced by NICE guideline NG97.

    Withdrawn guideline

  2. Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure (TA48)

    This guidance has been updated and replaced by NICE guideline NG107 

    Withdrawn guidance

  3. The clinical effectiveness and cost effectiveness of anakinra for rheumatoid arthritis (TA72)

    This appraisal has been updated and replaced by NICE guideline CG79. 

    Withdrawn guidance

  4. Hypertension in pregnancy: diagnosis and management (CG107)

    This guidance has been updated and replaced by NICE guideline NG133

    Withdrawn guideline

  5. Surgical site infections: prevention and treatment (CG74)

    This guidance has been updated and replaced by NICE guideline NG125.

    Withdrawn guideline

  6. Inducing labour (CG70)

    This guidance has been updated and replaced by NICE guideline NG207.

    Withdrawn guideline

  7. Attention deficit hyperactivity disorder: diagnosis and management (CG72)

    This guidance has been updated and replaced by NICE guideline NG87.

    Withdrawn guideline

  8. Glaucoma: diagnosis and management (CG85)

    This guidance has been updated and replaced by NICE guideline NG81.

    Withdrawn guideline

  9. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents (TA98)

    This guidance has been updated and replaced by NICE guideline NG87.

    Withdrawn guidance

  10. Parkinson's disease with motor fluctuations: safinamide (ES6)

    This evidence summary has been updated and replaced by NICE guideline NG71.

    Withdrawn advice

  11. Partial-onset seizures in epilepsy: zonisamide as monotherapy (ESNM17)

    This evidence summary has been updated and replaced by NICE guideline NG217.

    Withdrawn advice

  12. Attention deficit hyperactivity disorder in children and young people: lisdexamfetamine dimesylate (ESNM19)

    This evidence summary has been updated and replaced by NICE guideline NG87.

    Withdrawn advice

  13. Type 2 diabetes: alogliptin (ESNM20)

    This evidence summary has been updated and replaced by NICE guideline NG28.

    Withdrawn advice

  14. Chronic obstructive pulmonary disease: fluticasone furoate plus vilanterol (ESNM21)

    This evidence summary has been updated and replaced by NICE guideline 115.

    Withdrawn advice

  15. Asthma: beclometasone/formoterol (Fostair) for maintenance and reliever treatment (ESNM22)

    This evidence summary has been updated and replaced by NICE guideline NG80.

    Withdrawn advice